NCT04949867View on ClinicalTrials.gov

Dual-Hormone Closed-Loop Glucose Control in Adolescents With Type 1 Diabetes

PHASE4CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

May 20, 2021

Primary Completion Date

April 26, 2022

Study Completion Date

April 26, 2022

Conditions
Type 1 Diabetes
Interventions
DRUG

Glucagon

Glucagon is filled in the pump and given automatically in case of hypoglycemia or pending hypoglycemia.

DEVICE

Closed-loop System

Closed-loop system comprise of two DANA RS (R) insulin pumps (FiAsp-GlucaGen vs FiAsp-saline), one DexCom G6 sensor, and a smartphone for the control algorithm.

Trial Locations (2)

2730

Herlev Hospital, Herlev

2820

Steno Diabetes Center Copenhagen, Gentofte Municipality

All Listed Sponsors
collaborator

Technical University of Denmark

OTHER

collaborator

Herlev Hospital

OTHER

lead

Steno Diabetes Center Copenhagen

OTHER